100th つないで、進む FRONTIERS IN LIFE SCIENCE

検索の使い方

Breast Cancer And Normal Tissue Array, Including TNM And Pathology Grade, 2 Serial Sections, 48 Cases/96 Cores|ヒト組織アレイ

掲載日情報：2015/08/07 現在Webページ番号：172881

ティッシューアレイドットコム /
TissueArray.Com LLC
[メーカー略称：USB]

US Biomax社は、豊富なラインナップの組織アレイ、組織切片(凍結、FFPE)を提供しているメーカーです。
US Biomax社のヒト組織アレイ(Breast Cancer And Normal Tissue Array, Including TNM And Pathology Grade, 2 Serial Sections, 48 Cases/96 Cores)をご紹介します。

※ヒト組織アレイは、ドナーからインフォームドコンセントを取得した組織を使用しています。
※ドナーの組織は、HIV、Hepatitis B、Hepatitis Cが陰性であることを確認しています。
※本製品は研究用です。研究用以外には使用できません。

カートに商品を
追加しました。

ヒト組織アレイの価格

[在庫・価格 ：2024年06月11日 20時55分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。
詳細 商品名
  • 商品コード
  • メーカー
  • 包装
  • 価格
  • 在庫
  • 法規制等
 納期 文献数
Human Breast cancer and normal tissue array, including TNM and pathology grade, 2 serial sections, 48cases/96cores
  • お問い合わせ
 2～3週間 ※※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。 0
  • お問い合わせ
説明文
法規制等
保存条件 法規備考
掲載カタログ

製品記事 TissueArray.Com社 組織アレイ(Tissue array) 選択ガイド
関連記事 TissueArray.Com社 パラフィン組織スライド／組織アレイの仕様変更につきまして

[在庫・価格 ：2024年06月11日 20時55分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。

Human Breast cancer and normal tissue array, including TNM and pathology grade, 2 serial sections, 48cases/96cores

文献数： 0

  • お問い合わせ

説明文
法規制等
保存条件 法規備考
掲載カタログ

製品記事 TissueArray.Com社 組織アレイ(Tissue array) 選択ガイド
関連記事 TissueArray.Com社 パラフィン組織スライド／組織アレイの仕様変更につきまして
  • お問い合わせ

目次に戻る

カートに商品を
追加しました。

ヒト組織アレイの特長

Microarray Panel: Breast carcinoma and normal tissue microarray, containing 40 cases of invasive ductal carcinoma, 6 normal tissue, 2 adjacent normal tissue, single core per case, 2 serial sections, divided into two identical 48 core arrays
Cores: 96
組織アレイ
Cases: 48
Layout: 16 cols × 6 rows
Core Diameter: 2 mm
Thickness: 5 µm
Quality Control: Anti-Actin confirmed
Applications:

Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes: Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H and E: Hematoxylin and Eosin stained tissue array slide.

目次に戻る

カートに商品を
追加しました。

ヒト組織アレイの仕様表

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 F 54 Breast Invasive ductal carcinoma 1 I T1N0M0 Malignant
A2 2 F 47 Breast Invasive ductal carcinoma 1 I T1N0M0 Malignant
A3 3 F 46 Breast Invasive ductal carcinoma (duct hyperplasia of breast sparse) – IIa T2N0M0 Malignant
A4 4 F 45 Breast Invasive ductal carcinoma (sparse) 1 IIIa T4N0M0 Malignant
A5 5 F 50 Breast Invasive ductal carcinoma (sparse) 1 IIb T3N0M0 Malignant
A6 6 F 49 Breast Invasive ductal carcinoma 2 I T1N0M0 Malignant
A7 7 F 71 Breast Invasive ductal carcinoma 1 IIa T2N0M0 Malignant
A8 8 F 54 Breast Invasive ductal carcinoma (sparse) 1 I T1N0M0 Malignant
A9 9 F 54 Breast Invasive ductal carcinoma 1 I T1N0M0 Malignant
A10 10 F 47 Breast Invasive ductal carcinoma 1 I T1N0M0 Malignant
A11 11 F 46 Breast Invasive ductal carcinoma (duct hyperplasia of breast sparse) – IIa T2N0M0 Malignant
A12 12 F 45 Breast Invasive ductal carcinoma (sparse) 1 IIIa T4N0M0 Malignant
A13 13 F 50 Breast Invasive ductal carcinoma (sparse) 1 IIb T3N0M0 Malignant
A14 14 F 49 Breast Invasive ductal carcinoma 2 I T1N0M0 Malignant
A15 15 F 71 Breast Invasive ductal carcinoma 1 IIa T2N0M0 Malignant
A16 16 F 54 Breast Invasive ductal carcinoma (sparse) 1 I T1N0M0 Malignant
B1 17 F 48 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
B2 18 F 51 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
B3 19 F 38 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
B4 20 F 45 Breast Invasive ductal carcinoma 2 IIIb T4N1M0 Malignant
B5 21 F 41 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
B6 22 F 48 Breast Invasive ductal carcinoma 2 I T1N0M0 Malignant
B7 23 F 70 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
B8 24 F 40 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
B9 25 F 48 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
B10 26 F 51 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
B11 27 F 38 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
B12 28 F 45 Breast Invasive ductal carcinoma 2 IIIb T4N1M0 Malignant
B13 29 F 41 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
B14 30 F 48 Breast Invasive ductal carcinoma 2 I T1N0M0 Malignant
B15 31 F 70 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
B16 32 F 40 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
C1 33 F 48 Breast Invasive ductal carcinoma 2 IIb T3N0M0 Malignant
C2 34 F 45 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
C3 35 F 35 Breast Invasive ductal carcinoma 2 I T1N0M0 Malignant
C4 36 F 56 Breast Invasive ductal carcinoma 2 IIb T2N1M0 Malignant
C5 37 F 41 Breast Invasive ductal carcinoma 2 I T1N0M0 Malignant
C6 38 F 50 Breast Invasive ductal carcinoma 2 IIb T2N1M0 Malignant
C7 39 F 65 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
C8 40 F 40 Breast Invasive ductal carcinoma 2 I T1N0M0 Malignant
C9 41 F 48 Breast Invasive ductal carcinoma 2 IIb T3N0M0 Malignant
C10 42 F 45 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
C11 43 F 35 Breast Invasive ductal carcinoma 2 I T1N0M0 Malignant
C12 44 F 56 Breast Invasive ductal carcinoma 2 IIb T2N1M0 Malignant
C13 45 F 41 Breast Invasive ductal carcinoma 2 I T1N0M0 Malignant
C14 46 F 50 Breast Invasive ductal carcinoma 2 IIb T2N1M0 Malignant
C15 47 F 65 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
C16 48 F 40 Breast Invasive ductal carcinoma 2 I T1N0M0 Malignant
D1 49 F 74 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
D2 50 F 50 Breast Invasive ductal carcinoma 2 IIIa T2N2M0 Malignant
D3 51 F 62 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
D4 52 F 56 Breast Invasive ductal carcinoma 2 IIIb T4N1M0 Malignant
D5 53 F 58 Breast Invasive ductal carcinoma 2 IIIb T4N1M0 Malignant
D6 54 F 62 Breast Invasive ductal carcinoma 2 I T1N0M0 Malignant
D7 55 F 58 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
D8 56 F 52 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
D9 57 F 74 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
D10 58 F 50 Breast Invasive ductal carcinoma 2 IIIa T2N2M0 Malignant
D11 59 F 62 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
D12 60 F 56 Breast Invasive ductal carcinoma 2 IIIb T4N1M0 Malignant
D13 61 F 58 Breast Invasive ductal carcinoma 2 IIIb T4N1M0 Malignant
D14 62 F 62 Breast Invasive ductal carcinoma 2 I T1N0M0 Malignant
D15 63 F 58 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
D16 64 F 52 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
E1 65 F 54 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
E2 66 F 59 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
E3 67 F 62 Breast Invasive ductal carcinoma 3 IIa T2N0M0 Malignant
E4 68 F 52 Breast Invasive ductal carcinoma 3 IIa T2N0M0 Malignant
E5 69 F 52 Breast Invasive ductal carcinoma 2 IIIb T4N0M0 Malignant
E6 70 F 66 Breast Invasive ductal carcinoma 3 IIa T2N0M0 Malignant
E7 71 F 40 Breast Invasive ductal carcinoma 3 IIb T2N1M0 Malignant
E8 72 F 47 Breast Invasive ductal carcinoma (fibrofatty tissue) – IIa T2N0M0 Malignant
E9 73 F 54 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
E10 74 F 59 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
E11 75 F 62 Breast Invasive ductal carcinoma 3 IIa T2N0M0 Malignant
E12 76 F 52 Breast Invasive ductal carcinoma 3 IIa T2N0M0 Malignant
E13 77 F 52 Breast Invasive ductal carcinoma 2 IIIb T4N0M0 Malignant
E14 78 F 66 Breast Invasive ductal carcinoma 3 IIa T2N0M0 Malignant
E15 79 F 40 Breast Invasive ductal carcinoma 3 IIb T2N1M0 Malignant
E16 80 F 47 Breast Invasive ductal carcinoma (fibrofatty tissue) – IIa T2N0M0 Malignant
F1 81 F 21 Breast Normal breast tissue – – – Normal
F2 82 F 35 Breast Normal breast tissue – – – Normal
F3 83 F 19 Breast Normal breast tissue (fibrofatty tissue) – – – Normal
F4 84 F 27 Breast Normal breast tissue – – – Normal
F5 85 F 42 Breast Normal breast tissue – – – Normal
F6 86 F 50 Breast Normal breast duct tissue – – – Normal
F7 87 F 44 Breast Cancer adjacent normal breast tissue – – – NAT
F8 88 F 43 Breast Cancer adjacent normal breast tissue – – – NAT
F9 89 F 21 Breast Normal breast tissue – – – Normal
F10 90 F 35 Breast Normal breast tissue – – – Normal
F11 91 F 19 Breast Normal breast tissue (fibrofatty tissue) – – – Normal
F12 92 F 27 Breast Normal breast tissue – – – Normal
F13 93 F 42 Breast Normal breast tissue – – – Normal
F14 94 F 50 Breast Normal breast duct tissue – – – Normal
F15 95 F 44 Breast Cancer adjacent normal breast tissue – – – NAT
F16 96 F 43 Breast Cancer adjacent normal breast tissue – – – NAT

*For precise diagnosis, refer to pathology description.

目次に戻る

カートに商品を
追加しました。

ヒト組織アレイのFAQ

US BIOMAX社ヒト組織アレイのFAQはこちら。

目次に戻る

カートに商品を
追加しました。

お問い合わせ先

（テクニカルサポート 試薬担当）

reagent@funakoshi.co.jp

製品情報は掲載時点のものですが、価格表内の価格については随時最新のものに更新されます。お問い合わせいただくタイミングにより製品情報・価格などは変更されている場合があります。
表示価格に、消費税等は含まれていません。一部価格が予告なく変更される場合がありますので、あらかじめご了承下さい。